EUVIMEDEUVIMED entdecken
Leitlinie

Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline

Anna L Godfrey iD, Alesia A Khan iD, Andrew McGregor, Andrew J Innes, Mohammed Altohami, Nicholas C P Cross, Rebecca Frewin, Mamta Garg iD, Anna Green, Jacob Grinfeld, Donal P McLornan iD, Andrew J Wilson und 4 weitere

British Journal of Haematology · 2026-02 · 208 (2) · 471-485

DOI: 10.1111/bjh.70260 ↗

Kurz gefasst

Leitlinie in der Zeitschrift British Journal of Haematology, online erschienen am 04.12.2025. Verfasst von Anna L Godfrey und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: British Society for Haematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

diagnosismyeloproliferativeplateletsthrombocytosistriple negative

Autor:innen und Institutionen

  • Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK.
  • Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Haematology, University Hospitals Leicester NHS Trust, Leicester, UK.
  • Faculty of Medicine, University of Southampton, Southampton, UK.

ORCID-Profile: Anna L Godfrey, Alesia A Khan, Mamta Garg, Donal P McLornan

Förderung

  • British Society for Haematology

Zitieren

APA

Godfrey, A. L., Khan, A. A., McGregor, A., Innes, A. J., Altohami, M., Cross, N. C. P., Frewin, R., Garg, M., Green, A., Grinfeld, J., McLornan, D. P., Wilson, A. J., Harrison, C. N., Mead, A. J., Nangalia, J., & BSH Committee (2026). Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline. British Journal of Haematology, 208(2), 471-485. https://doi.org/10.1111/bjh.70260

Vancouver

Godfrey AL, Khan AA, McGregor A, Innes AJ, Altohami M, Cross NCP, et al. Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline. British Journal of Haematology. 2026;208(2):471-485. doi:10.1111/bjh.70260

BibTeX
@article{Godfrey2026,
  author = {Godfrey, Anna L and Khan, Alesia A and McGregor, Andrew and Innes, Andrew J and Altohami, Mohammed and Cross, Nicholas C P and Frewin, Rebecca and Garg, Mamta and Green, Anna and Grinfeld, Jacob and McLornan, Donal P and Wilson, Andrew J and Harrison, Claire N and Mead, Adam J and Nangalia, Jyoti and BSH Committee, BSH Committee},
  title = {Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {2},
  pages = {471--485},
  doi = {10.1111/bjh.70260}
}
Kostenlos starten →